Rates of overweight and obesity have more than doubled in the United States during the last three decades, according to a new analysis. By 2050, it’s anticipated that 213 million adults (age, > 25 ...
healthdigest.com on MSN
Side-by-side photos of news media personalities who have confirmed Ozempic or GLP-1 use
When your job involves facing the camera daily, there's pressure to stay slim. These news media celebrities have been open ...
GLP-1 medications like Ozempic and Zepbound are transforming chronic disease and weight management, with perimenopausal women among the most common users. Despite their high use in this group, women ...
The World Anti-Doping Agency (WADA) said it is now monitoring GLP-1 use among elite athletes, including at the Winter Olympics in Italy. Being ‘monitored’ does not mean a substance is prohibited; ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Women who used a GLP-1 before pregnancy were more likely ...
Long-term GLP-1 use slows medical cost growth, according to findings published Jan. 13 from professional services firm Aon. The firm analyzed 192,000 GLP-1 users from July 2022 to March 2025, ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Diabetes management-dose GLP-1 use reduces recurrent ...
About one in eight U.S. adults (12%) say they are currently taking a GLP-1 medication such as Ozempic or Wegovy for weight loss, diabetes, heart disease or another chronic condition, a new KFF Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results